EXTREME VASCULAR INTERVENTIONS

Ischemic Foot Program

April 22, 2010
Salone delle Feste

ISCHEMIC FOOT PROGRAM

8.00

Registration

9.00

Welcome and Introduction
A. Piaggesi

9.15

Opening Lecture
Chairman: A. Piaggesi
L'epidemiologia del piede diabetico ischemico
E. Faglia

9.45-11.00

Pathogenesis
Chairman: M. Edmonds
09.45	Insulin-resistance, inflammation and PAD A. Ceriello
10.05	Peculiarity of the diabetic macroangiopathy M. Edmonds
10.25	New markers for an old disease R. Miccoli
10.45	Discussion

11.00

For Debate
Is preliminary diagnostic assessment always necessary
before intervention?
Chairman: E. Minar
YES: I. Bargellini NO: J. Clerissi

12.00

Sala Perla
Symposium
Are latest results of coronary Drug Eluting Stent (DES)
in diabetic reliable?

with the support of Abbott Vascular

13.00

Lunch - Exhibition viewing

14.00

Lecture
Chairman: J. Apelqvist
The ischemic diabetic foot in Europe, insights from
the Eurodiale Study
N. Schaper

14.30-15.30

Co-morbidity
Chairmen: L.Ricci, G.Wolf
14.30	The heart-foot syndrome F. Liistro
14.50	The head-foot syndrome M. De Carlo
15.10	The kidney-foot syndrome G. Wolf

15.30-16.30

Medical therapy for the ulcerated ischemic foot
Chairman: J. Apelqvist
15.30	The anti infective therapy in the ischemic foot F. Menichetti
15.50	The role of metabolic control G. Ghirlanda
16.10	New indications for old drugs: the adjuvant therapies revisited L. Uccioli

16.30

For Debate
Antiplatelets vs anticoagulants in the management
of the diabetic patients with PAD
Chairman: E. Faglia
Antiplatelets: J. Dorffler-Melly
Anticoagulants: R. De Caterina

17.30-18.30

Sala Perla
Symposium

April 23, 2010
Salone delle Feste

ISCHEMIC FOOT PROGRAM

9.00

Lecture
Chairman: S. van Baal
A surgery dedicated to the diabetic foot
D. Armstrong

9.30-10.45

Surgical therapy
Chairman: A. Piaggesi , S. Van Baal
9.30	The perioperative management of diabetic foot patients B. Kuppers
9.50	Surgical drainage of the infected foot J. Aragon Sanchez
10.10	Surgical reconstructive techniques A. Piaggesi
10.30	Discussion

10.45

Clinical Cases
Chairmen: A. Piaggesi, E. Faglia
Panelists: G. Clerici, L. Dalla Paola, F. Romagnoli

11.30

Lecture
Chairman: L. Uccioli
Innovative approach to the treatment of severe diabetic foot infection: a new surgical protocol.
C. Caravaggi

12.00

Sala Perla
Symposium
The future of V.A.C. ® Therapy
with the support of KCI

13.00

Lunch - Exibition Viewing

14.30

Lecture
Chairman: N. Scaper
The stratification of the risk in the multi-complicated patient
J. Apelqvist

15.00

New technologies for the management
of the diabetic ischemic leg
Chairman A. Piaggesi

Frequency- modulated electromagnetic stimulation (FREMS) in the management of the ischemic leg
R. Da Ros
Nanotecnologies in the treatment for the prevention and rehabilitation of the ischemic leg
E. Banchellini

16.00

For Debate
Does revascularization always precede surgery?
Chairman: D. Armstrong
Yes: S. Van Baal No:G. Clerici

17.00-18.00
Sala Perla

FOR DEBATE (TOWARDS THE FUTURE)
Is there any need for a New Consensus on the indications and outcome measurements of revascularization in CLI?

Chairman: E. Faglia

Introduction:
A. Piaggesi

YES - Proofs of clinical inadequacy
E. Faglia

NO - Tasc II still remains valid
L. Norgren

Discussants:

Intervention through the last twenty years
A.Bolia

We have improved endovascular strategies in the ischemic foot
L. Graziani

The advantage of an integrated approach
A. Piaggesi

Suggestions to reliably measure the benefit of new techniques and devices
E. Minar

Discussion
Remarks and conclusion: E. Faglia, A. Piaggesi

with the support of Cook